Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma

Objective: To describe PNI and to evaluate its impact on disease-free (DFS) and overall survival (OS) in patients with resected pancreatic ductal adenocarcinoma (PDAC). Summary of Background Data: Although PNI is a prognostic factor for survival in many GI cancers, there is limited knowledge regarding its impact on tumor recurrence, especially in ‘‘early stage disease’’ (PDAC ≤20 mm, R0/ N0 PDAC). Methods: This multicenter retrospective study included patients undergoing PDAC resection between 2009 and 2014. The association of PNI with DFS and OS was analyzed using Cox proportional-hazards models. Results: PNI was found in 87% of 778 patients included in the study, with lower rates in PDAC ≤20 mm (78.7%) and in R0/N0 tumors (70.6%). PNI rate did not differ between patients who underwent neoadjuvant therapy and upfront surgery (88% vs 84%, P = 0.08). Although not significant at multivariate analysis (P = 0.07), patients with PNI had worse DFS at univariate analysis (median DFS: 20 vs 15 months, P < 0.01). PNI was the only independent predictor of DFS in R0/N0 tumors (hazard ratio [HR]: 2.2) and in PDAC ≤ 20 mm (HR: 1.8). PNI was an independent predictor of OS in the entire cohort (27 vs 50 months, P = 0.01), together with G3 tumors, pN1 status, carbohydrate antigen (CA) 19.9 >37 and pain. Conclusions: PNI represents a major determinant of tumor recurrence and patients’ survival in pancreatic cancer. The role of PNI is particularly relevant in early stages, supporting the hypothesis that invasion of nerves by cancer cells has a driving role in pancreatic cancer progression.

[1]  B. Erickson,et al.  Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery. , 2019, Surgery.

[2]  M. Falconi,et al.  Nerves and Pancreatic Cancer: New Insights into A Dangerous Relationship , 2019, Cancers.

[3]  C. Jiang,et al.  Tumor Neurobiology and the War of Nerves in Cancer. , 2019, Cancer discovery.

[4]  H. Friess,et al.  The impact of neoadjuvant therapy on the histopathological features of pancreatic ductal adenocarcinoma - A systematic review and meta-analysis. , 2017, Cancer treatment reviews.

[5]  H. Zeng,et al.  The impact of multifocal perineural invasion on biochemical recurrence and timing of adjuvant androgen‐deprivation therapy in high‐risk prostate cancer following radical prostatectomy , 2017, The Prostate.

[6]  H. Hondermarck,et al.  Nerve Dependence: From Regeneration to Cancer. , 2017, Cancer cell.

[7]  H. Friess,et al.  The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma - A systematic review and meta-analysis. , 2017, Surgical oncology.

[8]  B. Davis,et al.  Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer , 2016, Proceedings of the National Academy of Sciences.

[9]  J. Forbes,et al.  Nerve fibers infiltrate the tumor microenvironment and are associated with nerve growth factor production and lymph node invasion in breast cancer , 2015, Molecular oncology.

[10]  Jeffrey E. Lee,et al.  Neoadjuvant Therapy is Associated with a Reduced Lymph Node Ratio in Patients with Potentially Resectable Pancreatic Cancer , 2015, Annals of Surgical Oncology.

[11]  J. D'haese,et al.  The Impact of Neural Invasion Severity in Gastrointestinal Malignancies: A Clinicopathological Study , 2014, Annals of surgery.

[12]  A. Ayav,et al.  Is Perineural Invasion More Accurate Than Other Factors to Predict Early Recurrence after Pancreatoduodenectomy for Pancreatic Head Adenocarcinoma? , 2014, World Journal of Surgery.

[13]  R. DePinho,et al.  Neuroplastic changes occur early in the development of pancreatic ductal adenocarcinoma. , 2014, Cancer research.

[14]  S. Freedland,et al.  Autonomic Nerve Development Contributes to Prostate Cancer Progression , 2013, Science.

[15]  C. Verbeke,et al.  Resection margin involvement and tumour origin in pancreatic head cancer , 2012, The British journal of surgery.

[16]  H. Eguchi,et al.  Perineural Invasion and Lymph Node Involvement as Indicators of Surgical Outcome and Pattern of Recurrence in the Setting of Preoperative Gemcitabine-Based Chemoradiation Therapy for Resectable Pancreatic Cancer , 2012, Annals of surgery.

[17]  Hao Liu,et al.  Neurogenesis in colorectal cancer is a marker of aggressive tumor behavior and poor outcomes , 2011, Cancer.

[18]  H. Kitagawa,et al.  The Nature of Neural Invasion by Pancreatic Cancer , 2007, Pancreas.

[19]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[20]  K. Akita,et al.  Innervation of the Pancreas from the Perspective of Perineural Invasion of Pancreatic Cancer , 2003, Pancreas.

[21]  H. Ueno,et al.  Abdominal Pain in Patients with Resectable Pancreatic Cancer with Reference to Clinicopathologic Findings , 2001, Pancreas.

[22]  S. Okushiba,et al.  Perineural invasion by ductal adenocarcinoma of the pancreas , 1997, Journal of surgical oncology.

[23]  An Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer. , 2018, Cancer discovery.

[24]  Jeffrey W. Clark,et al.  "Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer." , 2017, Annals of surgery.

[25]  H. Friess,et al.  Pancreatic neuropathy and neuropathic pain--a comprehensive pathomorphological study of 546 cases. , 2009, Gastroenterology.

[26]  M. Monden,et al.  The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection , 2006, Surgery Today.

[27]  奥坂 拓志.  Abdominal pain in patients with resectable pancreatic cancer with reference to clinicopathologic findings , 2002 .